Piperidine amides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Authors:
- Katarina FlyrénKFKatarina Flyrén
- Lars O. BergquistLBLars O. Bergquist
- Victor M. CastroVCVictor M. Castro
- Christopher FotschCFChristopher Fotsch
- Lars JohanssonLJLars Johansson
- David J. St. JeanDJDavid J. St. Jean
- Lori SutinLSLori Sutin
- Meredith WilliamsMWMeredith Williams
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (12) , 3421-3425
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Recent progress in 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1) inhibitor developmentDrugs of the Future, 2006
- Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1Bioorganic & Medicinal Chemistry Letters, 2005
- Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: selective inhibitors of 11β-hydroxysteroid dehydrogenase type IBioorganic & Medicinal Chemistry Letters, 2005
- 11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseasesExpert Opinion on Therapeutic Patents, 2005
- 11β-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative diseaseExpert Opinion on Therapeutic Targets, 2003
- Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic miceDiabetologia, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stressProceedings of the National Academy of Sciences, 1997
- REGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSIONAnnual Review of Biochemistry, 1997
- CUSHING'S SYNDROME?KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSISThe Lancet, 1982